Urinary bladder tumours. The new 2004 WHO classification;Harnblasentumoren. Die neue WHO-klassifikation 2004

Urologe - Ausgabe A

Volumn 44, Issue 9, 2005, Pages 1073-1086

  Seitz, M ^a   Zaak, D ^a   Knuchel Clarke R ^b   Stief, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Molecular characterization; Subclassification; Urinary bladder carcinoma; Urothelial tumours; WHO classification

Indexed keywords

BLADDER TUMOR; CORRELATION ANALYSIS; GENETICS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; MORPHOLOGY; OUTCOMES RESEARCH; REVIEW; RISK ASSESSMENT; TUMOR CLASSIFICATION; UROTHELIUM; WORLD HEALTH ORGANIZATION;

HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; REFERENCE STANDARDS; URINARY BLADDER NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 24944457549     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-005-0901-x     Document Type: Review

References (15)

1. Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 130: 371-378
2. Mostofi FK, Sobin LH, Tosoni I (1973) Histological typing of urinary bladder tumours. International classification of tumours, No 19. World Health Organisation, Geneva
3. Sauter G, Algaba F, Amin M, Busch C, Cheville J, Gasser T et al. (2004) Non-invasive urothelial neoplasias. WHO classification of non-invasive papillary urothelial tumors. In: Eble JN, Sauter G, Epstein JI, Sesterhenn I, (eds) World Health Organization classification of tumors. Pathology and genetics: Tumors of the urinary system and male genital organs. IARCC Press, Lyon, pp 89-157
4. Mostofi FJ, Davis CJ, Sesterhenn IA et al. (eds) (1999) Histological typing of urinary bladder tumours. In: World Health Organization international histological classification of tumours. Springer, Berlin Heidelberg New York Tokio, pp 1-103
5. Epstein JI, Amin MB, Reuter VR et al. (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22: 1435-1448
6. Hartmann A, Schlake G, Zaak D, Hungerhuber E, Hofstetter A, Hofstaedter F, Knuechel R (2002) Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 62(3): 809-818
7. Lopez-Beltran A, Montironi R (2004) Non-invasive urothelial neoplasms: Accordingto the most recent WHO classification. Eur Urol 46: 170-176
8. Holmang S, Johansson SL (2002) Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167(4): 1634-1637
9. Humphrey PA (2004) Urinary bladder pathology 2004: an update. Ann Diagn Pathol 8(6): 380-389
10. Catto JW, Meuth M, Hamdy FC (2004) Genetic instability and transitional cell carcinoma of the bladder. BJU Int 93(1): 19-24
11. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL (2001) Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165: 1124-8, discussion 1128-1130
12. Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K (2003) Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 92: 559-562
13. Cheng L, Neumann RM, Bostwick DG (1999) Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications. Cancer 86:2102-2108
14. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002) Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 55:900-905
15. Larsson P, Wijkstrom H, Thorstenson A et al. (2003) A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 37(3):195-201